: The Core will serve all projects in this Program. The use of 2D gels and mass spectrometry (MS) represents the most efficient way to perform proteomic analyses. It is now possible to rapidly characterize 1,000-3,000 of the cellular proteins and to compare protein expression after specific manipulations of the cells. The Core will provide methodology for proteomics analysis based on 2-D gel electrophoresis coupled with in-gel digestion and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI/TOF) or liquid chromatography/tandem mass spectrometry (LC/MS/MS). Protein spots will be imaged and stored so that they can be compared with a single standard image. All spots will be excised from the gel but identification of differentially expressed spots will be the major goal of analyses that are performed. The other spots will be stored at -70 degree C in case other targets are discovered during subsequent research. The proteins present in gel cores will be subjected to in-gel digestion with subsequent extraction of the peptide fragments for analysis by MS. In-gel digestion will normally be conducted with trypsin using 96-wellplates. Samples will be de-salted prior to MS analyses using commercially available micro columns. The samples will then be spotted on MALDI-TOF targets or injected directly on an LC/MS system. In a typical proteome analysis, MALDI-TOF/MS will be conducted on peptide digests of the excised gel spots to rapidly obtain partial sequences. Mass measurements will be conducted with accuracy in the 5-10 ppm range by using internal calibration of protease fragments present in the incubation. This method will be particularly useful for proteins that appear in databases as it is possible to identify a protein with as few as 3-5 peptide fragments. For unknown peptides, this approach has only limited applicability. It will be necessary to use LC/MS/MS for the full structural characterization of unknown proteins. MS/MS analyses will also be conducted when necessary using partially purified peptide fragments in combination with nanospray infusions. Sequencing of unknown peptides will be performed using computer programs such as Sequest, MASCOT, peptidesearch, PROWL, and protein. The Sequest system works particularly well with marginal MS/MS data but does not allow searching on the internet. MASCOT will therefore serve as an ideal adjunct for web searching. This Core is an absolutely vital component of the PPG.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
1P50HL070128-01
Application #
6598255
Study Section
Special Emphasis Panel (ZHL1)
Project Start
2002-05-01
Project End
2007-03-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Patel, Parin J; Khera, Amit V; Wilensky, Robert L et al. (2013) Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy. Eur J Heart Fail 15:1215-9
Khera, Amit V; Cuchel, Marina; de la Llera-Moya, Margarita et al. (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 364:127-35
Yamamoto, Shigenori; Tanigawa, Hiroyuki; Li, Xiaoyu et al. (2011) Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport. Circulation 124:1382-90
Patel, Parin J; Khera, Amit V; Jafri, Kashif et al. (2011) The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease. J Am Coll Cardiol 58:2068-75
Lagor, William R; Rader, Daniel J (2011) Phospholipidation of HDL--how much is too much? Clin Chem 57:4-6
Nakaya, Kazuhiro; Tohyama, Junichiro; Naik, Snehal U et al. (2011) Peroxisome proliferator-activated receptor-? activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway. Arterioscler Thromb Vasc Biol 31:1276-82
Degoma, Emil M; Rader, Daniel J (2011) Novel HDL-directed pharmacotherapeutic strategies. Nat Rev Cardiol 8:266-77
Heffron, Sean P; Parastatidis, Ioannis; Cuchel, Marina et al. (2009) Inflammation induces fibrinogen nitration in experimental human endotoxemia. Free Radic Biol Med 47:1140-6
Parastatidis, Ioannis; Thomson, Leonor; Burke, Anne et al. (2008) Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor. J Biol Chem 283:33846-53
Price, Tom S; Baggs, Julie E; Curtis, Anne M et al. (2008) WAVECLOCK: wavelet analysis of circadian oscillation. Bioinformatics 24:2794-5

Showing the most recent 10 out of 55 publications